Simplex Trading
PCVX icon

Simplex Trading’s Vaxcyte PCVX Stock Holding History

Simplex Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$643K Sell
11,300
-1,700
-13% -$99.1K ﹤0.01% 3255
2026
Q2 		$756K Buy
13,000
+10,400
+400% +$565K ﹤0.01% 3104
2026
Q1 		$151K Buy
2,600
+2,500
+2,500% +$136K ﹤0.01% 4623
2025
Q4 		$4.61K Sell
100
-66,700
-100% -$2.98M ﹤0.01% 7479
2025
Q3 		$2.41M Buy
66,800
+33,500
+101% +$1.11M ﹤0.01% 2134
2025
Q2 		$1.08M Buy
33,300
+8,600
+35% +$282K ﹤0.01% 2700
2025
Q1 		$932K Buy
24,700
+14,400
+140% +$1.15M ﹤0.01% 2767
2024
Q4 		$843K Buy
10,300
+7,200
+232% +$715K ﹤0.01% 3017
2024
Q3 		$354K Sell
3,100
-13,700
-82% -$1.23M ﹤0.01% 3962
2024
Q2 		$1.27M Buy
16,800
+9,200
+121% +$626K ﹤0.01% 2677
2024
Q1 		$519K Buy
7,600
+2,900
+62% +$201K ﹤0.01% 3829
2023
Q4 		$295K Buy
4,700
+4,300
+1,075% +$223K ﹤0.01% 4251
2023
Q3 		$20K Sell
400
-20,400
-98% -$1.01M ﹤0.01% 6628
2023
Q2 		$1.04M Buy
20,800
+6,400
+44% +$303K ﹤0.01% 2558
2023
Q1 		$539K Buy
14,400
+14,100
+4,700% +$598K ﹤0.01% 3182
2022
Q4 		$14K Sell
300
-1,200
-80% -$47.1K ﹤0.01% 7225
2022
Q3 		$36K Hold
1,500
– – ﹤0.01% 6864
2022
Q2 		$32K Buy
+1,500
New +$34.7K ﹤0.01% 7066
2021
Q2 		– Sell
-1
Closed -$1K – 10536
2021
Q1 		$1K Buy
+1
New +$25 ﹤0.01% 8573

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Simplex Trading's PCVX Position: Q3 2026 in Review

Simplex Trading opened a new position in Vaxcyte (PCVX) in Q3 2026: 133 shares worth $7.57K. The stake represents ﹤0.01% of the portfolio and ranks #7825 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PCVX as recently as Q4 2025.

Simplex Trading first reported a position in PCVX in Q2 2022 and has held it in 7 quarters since. The position peaked at $1.05M in Q4 2024. 167 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Simplex Trading held 133 shares of Vaxcyte worth $7.57K as of Q3 2026.
  • Vaxcyte was a new Simplex Trading position in Q3 2026.
  • Vaxcyte made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #7825 holding.
  • Simplex Trading first reported a position in Vaxcyte in Q2 2022 and has held it in 7 quarters since.
  • Simplex Trading's Vaxcyte position peaked at $1.05M in Q4 2024.
  • 167 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.